Clinical Utility of the TRENDS Remote Monitoring Function Integrated into a Wearable Cardioverter-Defibrillator
Sensors · 22.06.2026 · 26 (12) · 3952
DOI: 10.3390/s26123952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, online erschienen am 22.06.2026. Verfasst von Yoshifumi Ikeda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka 350-1298, Saitama, Japan. Hauptthemen laut MEDLINE: Wearable Electronic Devices, Defibrillators, Implantable. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asahi Kasei (Japan), Asahi Kasei Zoll Medical.
Abstract (Originalsprache)
Background
Wearable cardioverter-defibrillators (WCDs) are equipped with the TRENDS remote-monitoring system, enabling continuous assessment of arrhythmias, physiological parameters, and patient-reported outcomes. This study evaluated the clinical utility of TRENDS-integrated WCD management and compared it with a historical control.
Methods
We prospectively analyzed 36 consecutive patients who received a WCD with TRENDS between 2019 and 2024 and compared them with 30 historical controls treated before the implementation of TRENDS.
Results
The WCD indications were heart failure as primary prevention (64%) and acute coronary syndrome with ventricular arrhythmias (28%). Among 18 patients who met the criteria for an implantable cardioverter-defibrillator (ICD), including 1 patient with WCD shock, 9 ultimately underwent ICD implantation. The mean daily WCD wear-time was 21.3 h and did not differ significantly from that of the historical control. The response rate to health-related questionnaires was 89%. TRENDS detected symptom exacerbation in 31% of patients, weight gain in 19% of patients, and missed medication in 19% of patients. Daily step-count was significantly lower in patients with ICD indications than in those without (5012 ± 2980 steps vs. 7977 ± 3584 steps, p = 0.01). TRENDS data also aided in initiating anticoagulation therapy and optimizing beta-blocker therapy.
Conclusions
TRENDS provided clinically actionable physiologic and patient-reported information that supported individualized cardiovascular management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka 350-1298, Saitama, Japan.
- Department of Nursing, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka 350-1298, Saitama, Japan.
ORCID-Profile: Yoshifumi Ikeda, Yoshitaka Terazaki
Förderung
- Asahi Kasei (Japan)
- Asahi Kasei Zoll Medical
Zitieren
APA
Ikeda, Y., Kanai, R., Terazaki, Y., Mori, H., Matsumoto, K., Narita, M., Sasaki, W., Naganuma, T., Tanaka, N., & Kato, R. (2026). Clinical Utility of the TRENDS Remote Monitoring Function Integrated into a Wearable Cardioverter-Defibrillator. Sensors, 26(12), 3952. https://doi.org/10.3390/s26123952
Vancouver
Ikeda Y, Kanai R, Terazaki Y, Mori H, Matsumoto K, Narita M, et al. Clinical Utility of the TRENDS Remote Monitoring Function Integrated into a Wearable Cardioverter-Defibrillator. Sensors. 2026;26(12):3952. doi:10.3390/s26123952
BibTeX
@article{Ikeda2026,
author = {Ikeda, Yoshifumi and Kanai, Risa and Terazaki, Yoshitaka and Mori, Hitoshi and Matsumoto, Kazuhisa and Narita, Masataka and Sasaki, Wataru and Naganuma, Tsukasa and Tanaka, Naomichi and Kato, Ritsushi},
title = {Clinical Utility of the TRENDS Remote Monitoring Function Integrated into a Wearable Cardioverter-Defibrillator},
journal = {Sensors},
year = {2026},
volume = {26},
number = {12},
pages = {3952},
doi = {10.3390/s26123952}
}
EUVIMED